 | • レポートコード：MRC2-11QY14583 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は人間用狂犬病ワクチンのグローバル市場について調査・分析したレポートです。種類別（予防ワクチン、緊急狂犬病ワクチン）市場規模、用途別（暴露前予防、暴露後予防）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別人間用狂犬病ワクチンの競争状況、市場シェア ・世界の人間用狂犬病ワクチン市場：種類別市場規模 2015年-2020年（予防ワクチン、緊急狂犬病ワクチン） ・世界の人間用狂犬病ワクチン市場：種類別市場規模予測 2021年-2026年（予防ワクチン、緊急狂犬病ワクチン） ・世界の人間用狂犬病ワクチン市場：用途別市場規模 2015年-2020年（暴露前予防、暴露後予防） ・世界の人間用狂犬病ワクチン市場：用途別市場規模予測 2021年-2026年（暴露前予防、暴露後予防） ・北米の人間用狂犬病ワクチン市場分析：米国、カナダ ・ヨーロッパの人間用狂犬病ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの人間用狂犬病ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の人間用狂犬病ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの人間用狂犬病ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Sanofi、GlaxoSmithKline、Merck、Chengda、Yisheng、Prcmise、VACN、Changsheng、BCHT、Hissen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Rabies Vaccine for Humans Market
The global Rabies Vaccine for Humans market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rabies Vaccine for Humans Scope and Market Size
Rabies Vaccine for Humans market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Vaccine for Humans market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rabies Vaccine for Humans market is segmented into
Preventative Vaccine
Emergency Rabies Vaccine
Segment by Application, the Rabies Vaccine for Humans market is segmented into
Pre-exposure prophylaxis
Post-exposure prophylaxis
Regional and Country-level Analysis
The Rabies Vaccine for Humans market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rabies Vaccine for Humans market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rabies Vaccine for Humans Market Share Analysis
Rabies Vaccine for Humans market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rabies Vaccine for Humans business, the date to enter into the Rabies Vaccine for Humans market, Rabies Vaccine for Humans product introduction, recent developments, etc.
The major vendors covered:
Novartis
Sanofi
GlaxoSmithKline
Merck
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
1 Study Coverage
1.1 Rabies Vaccine for Humans Product Introduction
1.2 Market Segments
1.3 Key Rabies Vaccine for Humans Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rabies Vaccine for Humans Market Size Growth Rate by Type
1.4.2 Preventative Vaccine
1.4.3 Emergency Rabies Vaccine
1.5 Market by Application
1.5.1 Global Rabies Vaccine for Humans Market Size Growth Rate by Application
1.5.2 Pre-exposure prophylaxis
1.5.3 Post-exposure prophylaxis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccine for Humans Market Size, Estimates and Forecasts
2.1.1 Global Rabies Vaccine for Humans Revenue 2015-2026
2.1.2 Global Rabies Vaccine for Humans Sales 2015-2026
2.2 Global Rabies Vaccine for Humans, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Rabies Vaccine for Humans Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rabies Vaccine for Humans Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rabies Vaccine for Humans Competitor Landscape by Players
3.1 Rabies Vaccine for Humans Sales by Manufacturers
3.1.1 Rabies Vaccine for Humans Sales by Manufacturers (2015-2020)
3.1.2 Rabies Vaccine for Humans Sales Market Share by Manufacturers (2015-2020)
3.2 Rabies Vaccine for Humans Revenue by Manufacturers
3.2.1 Rabies Vaccine for Humans Revenue by Manufacturers (2015-2020)
3.2.2 Rabies Vaccine for Humans Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rabies Vaccine for Humans Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rabies Vaccine for Humans Revenue in 2019
3.2.5 Global Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rabies Vaccine for Humans Price by Manufacturers
3.4 Rabies Vaccine for Humans Manufacturing Base Distribution, Product Types
3.4.1 Rabies Vaccine for Humans Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rabies Vaccine for Humans Product Type
3.4.3 Date of International Manufacturers Enter into Rabies Vaccine for Humans Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rabies Vaccine for Humans Market Size by Type (2015-2020)
4.1.1 Global Rabies Vaccine for Humans Sales by Type (2015-2020)
4.1.2 Global Rabies Vaccine for Humans Revenue by Type (2015-2020)
4.1.3 Rabies Vaccine for Humans Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rabies Vaccine for Humans Market Size Forecast by Type (2021-2026)
4.2.1 Global Rabies Vaccine for Humans Sales Forecast by Type (2021-2026)
4.2.2 Global Rabies Vaccine for Humans Revenue Forecast by Type (2021-2026)
4.2.3 Rabies Vaccine for Humans Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rabies Vaccine for Humans Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rabies Vaccine for Humans Market Size by Application (2015-2020)
5.1.1 Global Rabies Vaccine for Humans Sales by Application (2015-2020)
5.1.2 Global Rabies Vaccine for Humans Revenue by Application (2015-2020)
5.1.3 Rabies Vaccine for Humans Price by Application (2015-2020)
5.2 Rabies Vaccine for Humans Market Size Forecast by Application (2021-2026)
5.2.1 Global Rabies Vaccine for Humans Sales Forecast by Application (2021-2026)
5.2.2 Global Rabies Vaccine for Humans Revenue Forecast by Application (2021-2026)
5.2.3 Global Rabies Vaccine for Humans Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rabies Vaccine for Humans by Country
6.1.1 North America Rabies Vaccine for Humans Sales by Country
6.1.2 North America Rabies Vaccine for Humans Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rabies Vaccine for Humans Market Facts & Figures by Type
6.3 North America Rabies Vaccine for Humans Market Facts & Figures by Application
7 Europe
7.1 Europe Rabies Vaccine for Humans by Country
7.1.1 Europe Rabies Vaccine for Humans Sales by Country
7.1.2 Europe Rabies Vaccine for Humans Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rabies Vaccine for Humans Market Facts & Figures by Type
7.3 Europe Rabies Vaccine for Humans Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rabies Vaccine for Humans by Region
8.1.1 Asia Pacific Rabies Vaccine for Humans Sales by Region
8.1.2 Asia Pacific Rabies Vaccine for Humans Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rabies Vaccine for Humans Market Facts & Figures by Type
8.3 Asia Pacific Rabies Vaccine for Humans Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rabies Vaccine for Humans by Country
9.1.1 Latin America Rabies Vaccine for Humans Sales by Country
9.1.2 Latin America Rabies Vaccine for Humans Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rabies Vaccine for Humans Market Facts & Figures by Type
9.3 Central & South America Rabies Vaccine for Humans Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rabies Vaccine for Humans by Country
10.1.1 Middle East and Africa Rabies Vaccine for Humans Sales by Country
10.1.2 Middle East and Africa Rabies Vaccine for Humans Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rabies Vaccine for Humans Market Facts & Figures by Type
10.3 Middle East and Africa Rabies Vaccine for Humans Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Rabies Vaccine for Humans Products Offered
11.1.5 Novartis Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Rabies Vaccine for Humans Products Offered
11.2.5 Sanofi Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Rabies Vaccine for Humans Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Rabies Vaccine for Humans Products Offered
11.4.5 Merck Related Developments
11.5 Chengda
11.5.1 Chengda Corporation Information
11.5.2 Chengda Description and Business Overview
11.5.3 Chengda Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Chengda Rabies Vaccine for Humans Products Offered
11.5.5 Chengda Related Developments
11.6 Yisheng
11.6.1 Yisheng Corporation Information
11.6.2 Yisheng Description and Business Overview
11.6.3 Yisheng Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Yisheng Rabies Vaccine for Humans Products Offered
11.6.5 Yisheng Related Developments
11.7 Prcmise
11.7.1 Prcmise Corporation Information
11.7.2 Prcmise Description and Business Overview
11.7.3 Prcmise Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Prcmise Rabies Vaccine for Humans Products Offered
11.7.5 Prcmise Related Developments
11.8 VACN
11.8.1 VACN Corporation Information
11.8.2 VACN Description and Business Overview
11.8.3 VACN Sales, Revenue and Gross Margin (2015-2020)
11.8.4 VACN Rabies Vaccine for Humans Products Offered
11.8.5 VACN Related Developments
11.9 Changsheng
11.9.1 Changsheng Corporation Information
11.9.2 Changsheng Description and Business Overview
11.9.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Changsheng Rabies Vaccine for Humans Products Offered
11.9.5 Changsheng Related Developments
11.10 BCHT
11.10.1 BCHT Corporation Information
11.10.2 BCHT Description and Business Overview
11.10.3 BCHT Sales, Revenue and Gross Margin (2015-2020)
11.10.4 BCHT Rabies Vaccine for Humans Products Offered
11.10.5 BCHT Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Rabies Vaccine for Humans Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rabies Vaccine for Humans Market Estimates and Projections by Region
12.1.1 Global Rabies Vaccine for Humans Sales Forecast by Regions 2021-2026
12.1.2 Global Rabies Vaccine for Humans Revenue Forecast by Regions 2021-2026
12.2 North America Rabies Vaccine for Humans Market Size Forecast (2021-2026)
12.2.1 North America: Rabies Vaccine for Humans Sales Forecast (2021-2026)
12.2.2 North America: Rabies Vaccine for Humans Revenue Forecast (2021-2026)
12.2.3 North America: Rabies Vaccine for Humans Market Size Forecast by Country (2021-2026)
12.3 Europe Rabies Vaccine for Humans Market Size Forecast (2021-2026)
12.3.1 Europe: Rabies Vaccine for Humans Sales Forecast (2021-2026)
12.3.2 Europe: Rabies Vaccine for Humans Revenue Forecast (2021-2026)
12.3.3 Europe: Rabies Vaccine for Humans Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rabies Vaccine for Humans Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rabies Vaccine for Humans Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rabies Vaccine for Humans Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rabies Vaccine for Humans Market Size Forecast by Region (2021-2026)
12.5 Latin America Rabies Vaccine for Humans Market Size Forecast (2021-2026)
12.5.1 Latin America: Rabies Vaccine for Humans Sales Forecast (2021-2026)
12.5.2 Latin America: Rabies Vaccine for Humans Revenue Forecast (2021-2026)
12.5.3 Latin America: Rabies Vaccine for Humans Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rabies Vaccine for Humans Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rabies Vaccine for Humans Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rabies Vaccine for Humans Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rabies Vaccine for Humans Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Rabies Vaccine for Humans Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rabies Vaccine for Humans Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Rabies Vaccine for Humans Market Segments
Table 2. Ranking of Global Top Rabies Vaccine for Humans Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rabies Vaccine for Humans Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Preventative Vaccine
Table 5. Major Manufacturers of Emergency Rabies Vaccine
Table 6. Global Rabies Vaccine for Humans Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Rabies Vaccine for Humans Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Rabies Vaccine for Humans Sales by Regions 2015-2020 (K Units)
Table 9. Global Rabies Vaccine for Humans Sales Market Share by Regions (2015-2020)
Table 10. Global Rabies Vaccine for Humans Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Rabies Vaccine for Humans Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Rabies Vaccine for Humans Sales Share by Manufacturers (2015-2020)
Table 13. Global Rabies Vaccine for Humans Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Rabies Vaccine for Humans by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Vaccine for Humans as of 2019)
Table 15. Rabies Vaccine for Humans Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Rabies Vaccine for Humans Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Rabies Vaccine for Humans Price (2015-2020) (USD/Unit)
Table 18. Rabies Vaccine for Humans Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Rabies Vaccine for Humans Product Type
Table 20. Date of International Manufacturers Enter into Rabies Vaccine for Humans Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Rabies Vaccine for Humans Sales by Type (2015-2020) (K Units)
Table 23. Global Rabies Vaccine for Humans Sales Share by Type (2015-2020)
Table 24. Global Rabies Vaccine for Humans Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Rabies Vaccine for Humans Revenue Share by Type (2015-2020)
Table 26. Rabies Vaccine for Humans Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Rabies Vaccine for Humans Sales by Application (2015-2020) (K Units)
Table 28. Global Rabies Vaccine for Humans Sales Share by Application (2015-2020)
Table 29. North America Rabies Vaccine for Humans Sales by Country (2015-2020) (K Units)
Table 30. North America Rabies Vaccine for Humans Sales Market Share by Country (2015-2020)
Table 31. North America Rabies Vaccine for Humans Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Rabies Vaccine for Humans Revenue Market Share by Country (2015-2020)
Table 33. North America Rabies Vaccine for Humans Sales by Type (2015-2020) (K Units)
Table 34. North America Rabies Vaccine for Humans Sales Market Share by Type (2015-2020)
Table 35. North America Rabies Vaccine for Humans Sales by Application (2015-2020) (K Units)
Table 36. North America Rabies Vaccine for Humans Sales Market Share by Application (2015-2020)
Table 37. Europe Rabies Vaccine for Humans Sales by Country (2015-2020) (K Units)
Table 38. Europe Rabies Vaccine for Humans Sales Market Share by Country (2015-2020)
Table 39. Europe Rabies Vaccine for Humans Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Rabies Vaccine for Humans Revenue Market Share by Country (2015-2020)
Table 41. Europe Rabies Vaccine for Humans Sales by Type (2015-2020) (K Units)
Table 42. Europe Rabies Vaccine for Humans Sales Market Share by Type (2015-2020)
Table 43. Europe Rabies Vaccine for Humans Sales by Application (2015-2020) (K Units)
Table 44. Europe Rabies Vaccine for Humans Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Rabies Vaccine for Humans Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Rabies Vaccine for Humans Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Rabies Vaccine for Humans Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Rabies Vaccine for Humans Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Rabies Vaccine for Humans Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Rabies Vaccine for Humans Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Rabies Vaccine for Humans Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Rabies Vaccine for Humans Sales Market Share by Application (2015-2020)
Table 53. Latin America Rabies Vaccine for Humans Sales by Country (2015-2020) (K Units)
Table 54. Latin America Rabies Vaccine for Humans Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Rabies Vaccine for Humans Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Rabies Vaccine for Humans Revenue Market Share by Country (2015-2020)
Table 57. Latin America Rabies Vaccine for Humans Sales by Type (2015-2020) (K Units)
Table 58. Latin America Rabies Vaccine for Humans Sales Market Share by Type (2015-2020)
Table 59. Latin America Rabies Vaccine for Humans Sales by Application (2015-2020) (K Units)
Table 60. Latin America Rabies Vaccine for Humans Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Rabies Vaccine for Humans Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Rabies Vaccine for Humans Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Rabies Vaccine for Humans Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Rabies Vaccine for Humans Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Rabies Vaccine for Humans Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Rabies Vaccine for Humans Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Rabies Vaccine for Humans Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Rabies Vaccine for Humans Sales Market Share by Application (2015-2020)
Table 69. Novartis Corporation Information
Table 70. Novartis Description and Major Businesses
Table 71. Novartis Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Novartis Product
Table 73. Novartis Recent Development
Table 74. Sanofi Corporation Information
Table 75. Sanofi Description and Major Businesses
Table 76. Sanofi Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Sanofi Product
Table 78. Sanofi Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Merck Product
Table 88. Merck Recent Development
Table 89. Chengda Corporation Information
Table 90. Chengda Description and Major Businesses
Table 91. Chengda Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Chengda Product
Table 93. Chengda Recent Development
Table 94. Yisheng Corporation Information
Table 95. Yisheng Description and Major Businesses
Table 96. Yisheng Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Yisheng Product
Table 98. Yisheng Recent Development
Table 99. Prcmise Corporation Information
Table 100. Prcmise Description and Major Businesses
Table 101. Prcmise Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Prcmise Product
Table 103. Prcmise Recent Development
Table 104. VACN Corporation Information
Table 105. VACN Description and Major Businesses
Table 106. VACN Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. VACN Product
Table 108. VACN Recent Development
Table 109. Changsheng Corporation Information
Table 110. Changsheng Description and Major Businesses
Table 111. Changsheng Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Changsheng Product
Table 113. Changsheng Recent Development
Table 114. BCHT Corporation Information
Table 115. BCHT Description and Major Businesses
Table 116. BCHT Rabies Vaccine for Humans Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. BCHT Product
Table 118. BCHT Recent Development
Table 119. Hissen Corporation Information
Table 120. Hissen Description and Major Businesses
Table 121. Hissen Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Hissen Product
Table 123. Hissen Recent Development
Table 124. Global Rabies Vaccine for Humans Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Rabies Vaccine for Humans Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Rabies Vaccine for Humans Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Rabies Vaccine for Humans Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Rabies Vaccine for Humans Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Rabies Vaccine for Humans Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Rabies Vaccine for Humans Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Rabies Vaccine for Humans Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Rabies Vaccine for Humans Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Rabies Vaccine for Humans Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Rabies Vaccine for Humans Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Rabies Vaccine for Humans Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Rabies Vaccine for Humans Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Rabies Vaccine for Humans Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Rabies Vaccine for Humans Players
Table 142. Rabies Vaccine for Humans Customers List
Table 143. Rabies Vaccine for Humans Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Vaccine for Humans Product Picture
Figure 2. Global Rabies Vaccine for Humans Sales Market Share by Type in 2020 & 2026
Figure 3. Preventative Vaccine Product Picture
Figure 4. Emergency Rabies Vaccine Product Picture
Figure 5. Global Rabies Vaccine for Humans Sales Market Share by Application in 2020 & 2026
Figure 6. Pre-exposure prophylaxis
Figure 7. Post-exposure prophylaxis
Figure 8. Rabies Vaccine for Humans Report Years Considered
Figure 9. Global Rabies Vaccine for Humans Market Size 2015-2026 (US$ Million)
Figure 10. Global Rabies Vaccine for Humans Sales 2015-2026 (K Units)
Figure 11. Global Rabies Vaccine for Humans Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Rabies Vaccine for Humans Sales Market Share by Region (2015-2020)
Figure 13. Global Rabies Vaccine for Humans Sales Market Share by Region in 2019
Figure 14. Global Rabies Vaccine for Humans Revenue Market Share by Region (2015-2020)
Figure 15. Global Rabies Vaccine for Humans Revenue Market Share by Region in 2019
Figure 16. Global Rabies Vaccine for Humans Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Rabies Vaccine for Humans Revenue in 2019
Figure 18. Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Rabies Vaccine for Humans Sales Market Share by Type (2015-2020)
Figure 20. Global Rabies Vaccine for Humans Sales Market Share by Type in 2019
Figure 21. Global Rabies Vaccine for Humans Revenue Market Share by Type (2015-2020)
Figure 22. Global Rabies Vaccine for Humans Revenue Market Share by Type in 2019
Figure 23. Global Rabies Vaccine for Humans Market Share by Price Range (2015-2020)
Figure 24. Global Rabies Vaccine for Humans Sales Market Share by Application (2015-2020)
Figure 25. Global Rabies Vaccine for Humans Sales Market Share by Application in 2019
Figure 26. Global Rabies Vaccine for Humans Revenue Market Share by Application (2015-2020)
Figure 27. Global Rabies Vaccine for Humans Revenue Market Share by Application in 2019
Figure 28. North America Rabies Vaccine for Humans Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Rabies Vaccine for Humans Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Rabies Vaccine for Humans Sales Market Share by Country in 2019
Figure 31. North America Rabies Vaccine for Humans Revenue Market Share by Country in 2019
Figure 32. U.S. Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Rabies Vaccine for Humans Market Share by Type in 2019
Figure 37. North America Rabies Vaccine for Humans Market Share by Application in 2019
Figure 38. Europe Rabies Vaccine for Humans Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Rabies Vaccine for Humans Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Rabies Vaccine for Humans Sales Market Share by Country in 2019
Figure 41. Europe Rabies Vaccine for Humans Revenue Market Share by Country in 2019
Figure 42. Germany Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Rabies Vaccine for Humans Market Share by Type in 2019
Figure 53. Europe Rabies Vaccine for Humans Market Share by Application in 2019
Figure 54. Asia Pacific Rabies Vaccine for Humans Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Rabies Vaccine for Humans Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Rabies Vaccine for Humans Sales Market Share by Region in 2019
Figure 57. Asia Pacific Rabies Vaccine for Humans Revenue Market Share by Region in 2019
Figure 58. China Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Rabies Vaccine for Humans Market Share by Type in 2019
Figure 81. Asia Pacific Rabies Vaccine for Humans Market Share by Application in 2019
Figure 82. Latin America Rabies Vaccine for Humans Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Rabies Vaccine for Humans Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Rabies Vaccine for Humans Sales Market Share by Country in 2019
Figure 85. Latin America Rabies Vaccine for Humans Revenue Market Share by Country in 2019
Figure 86. Mexico Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Rabies Vaccine for Humans Market Share by Type in 2019
Figure 93. Latin America Rabies Vaccine for Humans Market Share by Application in 2019
Figure 94. Middle East and Africa Rabies Vaccine for Humans Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Rabies Vaccine for Humans Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Rabies Vaccine for Humans Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Rabies Vaccine for Humans Revenue Market Share by Country in 2019
Figure 98. Turkey Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Rabies Vaccine for Humans Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Rabies Vaccine for Humans Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Rabies Vaccine for Humans Market Share by Type in 2019
Figure 105. Middle East and Africa Rabies Vaccine for Humans Market Share by Application in 2019
Figure 106. North America Rabies Vaccine for Humans Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Rabies Vaccine for Humans Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Rabies Vaccine for Humans Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Rabies Vaccine for Humans Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Rabies Vaccine for Humans Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Rabies Vaccine for Humans Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Rabies Vaccine for Humans Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Rabies Vaccine for Humans Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Rabies Vaccine for Humans Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Rabies Vaccine for Humans Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
ヒト狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Rabies Vaccine Market The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Rabies Vaccine Scope and Market Size Human Rabies Vaccine market is…- 狂犬病治療の世界市場（～2026年） Market Analysis and Insights: Global Rabies Treatment Market The global Rabies Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rabies Treatment Scope and Market Size Rabies Treatment market is segmented by Ty…
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- アデノウイルスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Adenovirus Vaccine Market The global Adenovirus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adenovirus Vaccine Scope and Market Size Adenovirus Vaccine market is segment…